Jeff Aronin's startup incubator scoops ex-Alkermes exec Jim Robinson for new president/COO role
After a stint at Alkermes $ALKS that took him to Boston area for a little over a year, Jim Robinson is moving home.
Reporting at Paragon Biosciences’ Chicago office today, Robinson will keep the same title: president and chief operating officer. But instead of overseeing one entity, he will run a host of functional services to support Paragon’s six and counting portfolio companies.
Serving on Paragon’s advisory board for the past two years has given him “a bird’s eye view” not only on its mission and business model, but also the team that chairman and CEO Jeff Aronin has assembled. Over the last 18 months, they have pooled close to $500 million in investment for the biotech startups they launched, got up and running, then set sail as independently run operations.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.